Search Results

You are looking at 51 - 60 of 488 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

Renee W. Pinsky and Mark A. Helvie

Group convened in 2007 in recognition of the limitations of the current risk model. 31 They have proposed a new comprehensive risk-predicting model that would include breast density, estrogen, and androgen assays and measurements such as BMI. MRI, with

Full access

Michelle T. Ashworth and Adil Daud

right leg and scrotal lymphedema, and high-dose interferon followed by a subcutaneous interferon for 1 year. The patient was monitored with serial PET/CT, MRI brain, and clinical examination. In 2007, a left calf melanoma in situ was treated with WLE. In

Full access

Christopher J. Long, Sameer Mittal, and Thomas F. Kolon

techniques and refinement in MRI modalities yield a more precise assessment of the tumor size, correlation with histologic subtype and response to chemotherapy, as well as anatomic considerations related to PN. 34 , 35 Tumor extension beyond the kidney

Full access

Neil K. Taunk, Daniel E. Spratt, Mark Bilsky, and Yoshiya Yamada

, with a trend toward improved intracranial control. In a Cleveland Clinic series, patients receiving more than 30 Gy of WBRT survived longer than those receiving 30 Gy or Figure 2 T1-weighted axial MRI in 74-year-old woman showing (A) L3 body and

Full access

Lindsey M. Charo, Adam M. Burgoyne, Paul T. Fanta, Hitendra Patel, Juliann Chmielecki, Jason K. Sicklick, and Michael T. McHale

history nor family history of malignancy. Transabdominal ultrasound evaluation was unremarkable except for the unexpected finding of a 13.9 x 6.2 x 9.2-cm complex right adnexal mass ( Figure 1A ). An MRI to further evaluate the mass confirmed a 14-cm

Full access

Heidi Ko, Yaser Baghdadi, Charito Love, and Joseph A. Sparano

sonography, and in many cases MRI according to the AJCC Cancer Staging Manual , seventh edition. 14 It was the policy of the breast medical oncology service at Montefiore Medical Center during this time period to recommend FDG PET/CT as the preferred

Full access

Yifan Wang, Adeline Cuggia, Yen-I Chen, Josée Parent, Agatha Stanek, Robert E. Denroche, Amy Zhang, Robert C. Grant, Céline Domecq, Bryn Golesworthy, Chaya Shwaartz, Ayelet Borgida, Spring Holter, Julie M. Wilson, George Chong, Grainne M. O’Kane, Jennifer J. Knox, Sandra E. Fischer, Steven Gallinger, Zu-Hua Gao, William D. Foulkes, Kevin A. Waschke, and George Zogopoulos

inclusion criteria, imaging modalities, and surveillance intervals. NCCN, the Cancer of the Pancreas Screening (CAPS) Consortium, and the American College of Gastroenterology recommend surveillance with annual MRI and/or endoscopic ultrasound (EUS). 4 , 7

Full access

Shantanu Tyagi, Arandam Roy, Ravimohan Mavuduru, Girdhar Bora, Tushar Aditya Narain, and Arup Kumar Mandal

) among postoperative patients from a tertiary care center of a developing country. Materials & Method: Prospective cohort/next 50 group, surgery between July 2017 to September 2018: Preoperative variables included demographic profile, MRI findings, PSA

Full access

rationale for the treatment of transfusional iron overload in patients with myelodysplastic syndromes (MDS). The task force was charged with addressing issues related to tissue iron toxicity; the role of MRI in assessing iron overload; the rationale and role

Full access

Michael G. Milligan, Angel M. Cronin, Yolonda Colson, Kenneth Kehl, Debra N. Yeboa, Deborah Schrag, and Aileen B. Chen

Background The brain is a common site of metastasis for non–small cell lung cancer (NSCLC), and many patients undergo brain imaging with MRI or CT before definitive treatment. The hope is that early detection of brain metastases can expedite